FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:189-200 July 19, 2001 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In the 1980s, after decades of steadily declining rates of tuberculosis, ambitious plans were made to eliminate the disease in the United States. Despite these plans, the control of tuberculosis was neglected, resulting in a resurgence of the disease.¹ This resurgence has reminded us that the overall goal of public health programs must be not merely the provision of health care for marginalized persons, but a systematic commitment to protect the health of the general public in a time of increasing globalization. Regrettably, these lessons have come at considerable costs, in terms of both individual health and health care budgets.

. . . [Full Text of this Article]

Epidemiologic Features

Clinical Consequences of Infection

Treatment of Disease

Antituberculosis Drugs

Current Recommendations

Treatment in Special Situations

HIV-Infected Patients

Extrapulmonary Tuberculosis

Drug-Resistant Tuberculosis

Management of Latent Tuberculosis Infection

Candidates for Tuberculin Skin Testing

Interpreting Tuberculin Skin Test Results

Choosing a Treatment Regimen

New Research

Conclusions

Source Information

From the Division of Infectious Diseases and Geographic Medicine, Stanford University Medical Center, Stanford, Calif. (P.M.S.); the Tuberculosis Control Program, New York City Department of Health, New York (P.I.F.); and the Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta (P.I.F.).

Address reprint requests to Dr. Small at the Division of Infectious Diseases and Geographic Medicine, Stanford University Medical Center, Rm. S-156, Stanford, CA 94305, or at peter@molepi.stanford.edu.

References

This article has been cited by other articles:

• Park, S. H., Yang, S.-K., Yang, D.-H., Kim, K. J., Yoon, S. M., Choe, J. W., Ye, B. D., Byeon, J.-S., Myung, S.-J., Kim, J.-H. (2009). Prospective Randomized Trial of Six-Month versus Nine-Month Therapy for Intestinal Tuberculosis. Antimicrob. Agents Chemother. 53: 4167-4171 [Abstract] [Full Text]  
• Chang, S. T., Linderman, J. J., Kirschner, D. E. (2008). Effect of Multiple Genetic Polymorphisms on Antigen Presentation and Susceptibility to Mycobacterium tuberculosis Infection. Infect. Immun. 76: 3221-3232 [Abstract] [Full Text]  
• Raval, A., Akhavan-Toyserkani, G., Brinker, A., Avigan, M. (2007). Brief Communication: Characteristics of Spontaneous Cases of Tuberculosis Associated with Infliximab. ANN INTERN MED 147: 699-702 [Abstract] [Full Text]  
• Clark, P. M., Karagoz, T., Apikoglu-Rabus, S., Izzettin, F. V. (2007). Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm 64: 497-505 [Abstract] [Full Text]  
• Sester, U., Junker, H., Hodapp, T., Schutz, A., Thiele, B., Meyerhans, A., Kohler, H., Sester, M. (2006). Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 21: 3258-3268 [Abstract] [Full Text]  
• PEREZ, A., BROWN, H. S. III, RESTREPO, B. I. (2006). ASSOCIATION BETWEEN TUBERCULOSIS AND DIABETES IN THE MEXICAN BORDER AND NON-BORDER REGIONS OF TEXAS. Am J Trop Med Hyg 74: 604-611 [Abstract] [Full Text]  
• Thomas, D.-J. (2006). Mycobacterial Diseases in HIV-Positive Patients. Journal of Pharmacy Practice 19: 10-16 [Abstract]  
• (2005). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States. Am. J. Respir. Crit. Care Med. 172: 1169-1227 [Full Text]  
• Takasu, N., Takara, M., Komiya, I. (2005). Rifampin-Induced Hypothyroidism in Patients with Hashimoto's Thyroiditis. NEJM 352: 518-519 [Full Text]  
• Giles, J. T., Bathon, J. M. (2004). Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases. J Intensive Care Med 19: 320-334 [Abstract]  
• Sabayev, V., Yein, T., Khan, R. (2004). A rare case of tuberculosis sinusitis in an immunocompetent patient. Chest Meeting 126: 973S-974S [Abstract] [Full Text]  
• Aoki, K., Matsumoto, S., Hirayama, Y., Wada, T., Ozeki, Y., Niki, M., Domenech, P., Umemori, K., Yamamoto, S., Mineda, A., Matsumoto, M., Kobayashi, K. (2004). Extracellular Mycobacterial DNA-binding Protein 1 Participates in Mycobacterium-Lung Epithelial Cell Interaction through Hyaluronic Acid. J. Biol. Chem. 279: 39798-39806 [Abstract] [Full Text]  
• Shrestha, N. K., Tuohy, M. J., Hall, G. S., Reischl, U., Gordon, S. M., Procop, G. W. (2003). Detection and Differentiation of Mycobacterium tuberculosis and Nontuberculous Mycobacterial Isolates by Real-Time PCR. J. Clin. Microbiol. 41: 5121-5126 [Abstract] [Full Text]  
• Yew, W. W., Chan, C. K., Leung, C. C., Chau, C. H., Tam, C. M., Wong, P. C., Lee, J. (2003). Comparative Roles of Levofloxacin and Ofloxacin in the Treatment of Multidrug-Resistant Tuberculosis: Preliminary Results of a Retrospective Study From Hong Kong. Chest 124: 1476-1481 [Abstract] [Full Text]  
• Florczyk, M. A., McCue, L. A., Purkayastha, A., Currenti, E., Wolin, M. J., McDonough, K. A. (2003). A Family of acr-Coregulated Mycobacterium tuberculosis Genes Shares a Common DNA Motif and Requires Rv3133c (dosR or devR) for Expression. Infect. Immun. 71: 5332-5343 [Abstract] [Full Text]  
• Guttmacher, A. E., Collins, F. S. (2002). Genomic Medicine -- A Primer. NEJM 347: 1512-1520 [Full Text]  
• Mathew, P., Kuo, Y.-H., Vazirani, B., Eng, R. H. K., Weinstein, M. P. (2002). Are Three Sputum Acid-Fast Bacillus Smears Necessary for Discontinuing Tuberculosis Isolation?. J. Clin. Microbiol. 40: 3482-3484 [Abstract] [Full Text]  
• Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C., Behar, S. M. (2002). Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity. Infect. Immun. 70: 4501-4509 [Abstract] [Full Text]  
• Tsuda, A., Rogers, R. A., Hydon, P. E., Butler, J. P. (2002). Chaotic mixing deep in the lung. Proc. Natl. Acad. Sci. USA 99: 10173-10178 [Abstract] [Full Text]  
• Hill, A. R., Cohn, D. L., O'Brien, R. J. (2002). "TREATMENT OF LTBI": SELLING POINT OR SEMANTIC BLUNDER?. Am. J. Respir. Crit. Care Med. 165: 1338-1338 [Full Text]  
• NITTA, A. T., KNOWLES, L. S., KIM, J., LEHNKERING, E. L., BORENSTEIN, L. A., DAVIDSON, P. T., HARVEY, S. M., DE KONING, M. L. (2002). Limited Transmission of Multidrug-Resistant Tuberculosis Despite a High Proportion of Infectious Cases in Los Angeles County, California. Am. J. Respir. Crit. Care Med. 165: 812-817 [Abstract] [Full Text]  
• Baden, L. R., Horowitz, G., Jacoby, H., Eliopoulos, G. M. (2001). Quinolones and False-Positive Urine Screening for Opiates by Immunoassay Technology. JAMA 286: 3115-3119 [Abstract] [Full Text]  
• CARVALHO, A. C. C., DERIEMER, K., NUNES, Z. B., MARTINS, M., COMELLI, M., MARINONI, A., KRITSKI, A. L. (2001). Transmission of Mycobacterium tuberculosis to Contacts of HIV-infected Tuberculosis Patients. Am. J. Respir. Crit. Care Med. 164: 2166-2171 [Abstract] [Full Text]  
• Leiner, S., Blumberg, H. M., del Rio, C., Fantry, L. E., Meissner, P.E., Coulter, J.B.S., Small, P. M. (2001). Management of Tuberculosis. NEJM 345: 1501-1502 [Full Text]